| Symbol: |
C5orf64
|
| Description: |
chromosome 5 open reading frame 64 [Source:HGNC Symbol;Acc:26744]
|
| Location: |
Chr5:60933535-61047590[+]
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:110
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| C5orf64 |
Thiothixene |
0.007 |
Up |
| C5orf64 |
Lobinaline, monohydrochloride |
0.042 |
Up |
| C5orf64 |
Crotonosid |
0.028 |
Down |
| C5orf64 |
NSC 128166 |
0.028 |
Up |
| C5orf64 |
Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) |
0.041 |
Up |
| C5orf64 |
NSC 13477 |
0.002 |
Up |
| C5orf64 |
AT 116, benzylamine salt |
0.002 |
Up |
| C5orf64 |
Ethanesulfonic acid, compd. with 2-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]acetanilide (1:1) |
0.007 |
Up |
| C5orf64 |
as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- |
0.025 |
Up |
| C5orf64 |
NSC 15795 |
0.001 |
Up |
| C5orf64 |
Pimozide |
0.013 |
Up |
| C5orf64 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.028 |
Up |
| C5orf64 |
NSC 17753 |
0.034 |
Up |
| C5orf64 |
2-Imidazoline-1-ethanol, .alpha.,4,4-trimethyl-2-undecyl- |
0.009 |
Up |
| C5orf64 |
Methanaminium, N-[bis[4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,2-benzenedicarboxylate (1:1) |
0.043 |
Up |
Expression pattern: Sensitivity / Resistance
Total:8 Current:1
[First] [Prev] Next Last
|
| SNP:
~ Export ~
|
Records:44
Total:3 Current:1
[First] [Prev] Next Last
|
| miRNA:
~ Export ~
|
Records:null
| Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|